Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss

Details for Australian Patent Application No. 2004251641 (hide)

Owner Synta Pharmaceuticals, Corp

Inventors Koya, Keizo; Ono, Mitsunori; Wada, Yumiko; Nagai, Masazumi; Sun, Lijun

Agent Griffith Hack

Pub. Number AU-A-2004251641

PCT Pub. Number WO2005/000404

Priority 60/474,410 29.05.03 US; 60/474,550 29.05.03 US; 60/474,502 29.05.03 US

Filing date 28 May 2004

Wipo publication date 6 January 2005

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000404 Priority application(s): WO2005/000404

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251647-Abuse resistant amphetamine compounds

2004251638-Methods of making plants that exhibit enhanced disease resistance